Next-generation biotherapeutics utilize a novel biomolecules and delivery mechanisms to tackle disease. Grown in cell media, these therapeutics require a variety of chemical and physical characterization steps to ensure quality during manufacturing and promote basic understanding during development. From protein secondary structure analysis with Raman; to rapid infectious titer determination with simultaneous multi-laser NanoTracking Analysis; to AAV characterization and vaccine batch release with the A-TEEM fluorescence method, HORIBA provide answers that matter, providing insight into biotherapeutics, from development to manufacturing.

Browse Applications

 ↑ Back to Top